Jade Biosciences Inc
(JBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 74,596 | 81,409 | 53,237 | 23,022 | 8,889 |
| Operating Income | -74,596 | -81,409 | -53,237 | -23,022 | -8,889 |
| Other Income | 5,023 | 5,944 | 1,751 | 62 | -722 |
| Pre-tax Income | -69,573 | -75,465 | -51,486 | -22,960 | -9,611 |
| Income Tax | 55 | 56 | 25 | 3 | N/A |
| Net Income Continuous | -69,628 | -75,521 | -51,511 | -22,963 | -9,611 |
| Net Income | $-69,628 | $-75,521 | $-51,511 | $-22,963 | $-9,611 |
| EPS Basic Total Ops | -85.61 | -100.70 | -73.68 | -65.61 | -1,414.39 |
| EPS Basic Continuous Ops | -85.48 | -100.63 | -73.86 | -65.54 | -1,393.51 |
| EPS Diluted Total Ops | -85.61 | -100.70 | -73.68 | -65.61 | -1,414.39 |
| EPS Diluted Continuous Ops | -85.48 | -100.63 | -73.86 | -65.54 | -1,393.51 |
| EPS Diluted Before Non-Recurring Items | -85.61 | -100.70 | -73.68 | -65.61 | N/A |
| EBITDA(a) | $-76,562 | $-84,370 | $-54,079 | $-22,991 | $-8,888 |